KARNALYTE RESOURCES INC (KRN.CA) Fundamental Analysis & Valuation

TSX:KRN • CA4856722083

Current stock price

0.34 CAD
-0.01 (-4.23%)
Last:

This KRN.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. KRN.CA Profitability Analysis

1.1 Basic Checks

  • In the past year KRN has reported negative net income.
  • KRN had a negative operating cash flow in the past year.
  • KRN had negative earnings in each of the past 5 years.
  • KRN had a negative operating cash flow in each of the past 5 years.
KRN.CA Yearly Net Income VS EBIT VS OCF VS FCFKRN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

  • KRN has a worse Return On Assets (-16.19%) than 64.29% of its industry peers.
  • KRN has a Return On Equity (-25.22%) which is in line with its industry peers.
Industry RankSector Rank
ROA -16.19%
ROE -25.22%
ROIC N/A
ROA(3y)-19.94%
ROA(5y)-23.31%
ROE(3y)-27.54%
ROE(5y)-32.76%
ROIC(3y)N/A
ROIC(5y)N/A
KRN.CA Yearly ROA, ROE, ROICKRN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for KRN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KRN.CA Yearly Profit, Operating, Gross MarginsKRN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

5

2. KRN.CA Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for KRN remains at a similar level compared to 1 year ago.
  • KRN has more shares outstanding than it did 5 years ago.
  • KRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
KRN.CA Yearly Shares OutstandingKRN.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
KRN.CA Yearly Total Debt VS Total AssetsKRN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

  • KRN has an Altman-Z score of -27.21. This is a bad value and indicates that KRN is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -27.21, KRN is doing worse than 78.57% of the companies in the same industry.
  • KRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -27.21
ROIC/WACCN/A
WACCN/A
KRN.CA Yearly LT Debt VS Equity VS FCFKRN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

  • KRN has a Current Ratio of 1.58. This is a normal value and indicates that KRN is financially healthy and should not expect problems in meeting its short term obligations.
  • KRN's Current ratio of 1.58 is in line compared to the rest of the industry. KRN outperforms 50.00% of its industry peers.
  • KRN has a Quick Ratio of 1.58. This is a normal value and indicates that KRN is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.58, KRN is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.58
KRN.CA Yearly Current Assets VS Current LiabilitesKRN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

0

3. KRN.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 38.80% over the past year.
EPS 1Y (TTM)38.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-81.13%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. KRN.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for KRN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KRN.CA Price Earnings VS Forward Price EarningsKRN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KRN.CA Per share dataKRN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. KRN.CA Dividend Analysis

5.1 Amount

  • No dividends for KRN!.
Industry RankSector Rank
Dividend Yield 0%

KRN.CA Fundamentals: All Metrics, Ratios and Statistics

KARNALYTE RESOURCES INC

TSX:KRN (4/21/2026, 7:00:00 PM)

0.34

-0.01 (-4.23%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)03-27
Earnings (Next)05-08
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap18.12M
Revenue(TTM)N/A
Net Income(TTM)-1.02M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.48
P/tB 4.48
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.08
TBVpS0.08
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -16.19%
ROE -25.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-19.94%
ROA(5y)-23.31%
ROE(3y)-27.54%
ROE(5y)-32.76%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6615.38%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.58
Quick Ratio 1.58
Altman-Z -27.21
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)6983.33%
Cap/Depr(5y)4698%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-81.13%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y18.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-7.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.26%
OCF growth 3YN/A
OCF growth 5YN/A

KARNALYTE RESOURCES INC / KRN.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of KARNALYTE RESOURCES INC (KRN.CA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to KRN.CA.


Can you provide the valuation status for KARNALYTE RESOURCES INC?

ChartMill assigns a valuation rating of 0 / 10 to KARNALYTE RESOURCES INC (KRN.CA). This can be considered as Overvalued.


How profitable is KARNALYTE RESOURCES INC (KRN.CA) stock?

KARNALYTE RESOURCES INC (KRN.CA) has a profitability rating of 0 / 10.